HomeBUSINESS
BUSINESS

Shionogi Ups Earnings Outlook on Milestone Scheme Change
(Oct.24.2017)

Shionogi said on October 23 that it has lifted its first-half earnings forecast as robust PIII data for its sakigake-designated flu drug S-033188 has prompted a revision to a milestone arrangement with its global partner Roche, which resulted in an earlier payment from the Swiss giant ...
(LOG IN FOR FULL STORY)

News Calendar